SCHEMBL19655515

SCHEMBL19655515

CC(C)C(=O)Oc1ccc(CO)cc1C(=O)OC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 2/20 0.48
▸ CHRM2 P08172 1/20 0.45
▸ CHRM1 P11229 1/20 0.45
▸ ADRB2 P07550 2/20 0.44
▸ ADRA2A P08913 1/20 0.44
▸ DRD2 P14416 1/20 0.44
▸ ADRA2C P18825 1/20 0.44
▸ DRD1 P21728 1/20 0.44
▸ ADRA1A P35348 1/20 0.44
▸ DRD3 P35462 1/20 0.44
▸ CFD P00746 1/20 0.37
▸ CYP4F2 P78329 1/20 0.37
▸ CYP4A11 Q02928 1/20 0.37
▸ MTNR1A P48039 1/20 0.36
▸ MTNR1B P49286 1/20 0.36
▸ P2RX3 P56373 1/20 0.36
▸ ADRB1 P08588 1/20 0.35
▸ ADRB3 P13945 1/20 0.35
▸ FGFR1 P11362 2/20 0.35
▸ EGFR P00533 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30206724 1.00 ALOX15 (0.48) ALOX15CHRM2CHRM1ADRB2ADRA2A
SCHEMBL22733403 0.85 CFD (0.52) CHRM2CHRM1CFDCYP4F2CYP4A11
SCHEMBL30206648 0.82 CFD (0.55) ALOX15CHRM2CHRM1ADRB2ADRA2A
SCHEMBL19640086 0.82 CFD (0.55) ALOX15CHRM2CHRM1ADRB2ADRA2A
SCHEMBL30394978 0.82 MTNR1A (0.46) CYP4F2CYP4A11MTNR1AMTNR1BCA12
SCHEMBL19655516 0.80 ALDH1A1 (0.41) ALOX15ADRB2ADRA2ADRD2ADRA2C
SCHEMBL30206796 0.80 ALDH1A1 (0.41) ALOX15ADRB2ADRA2ADRD2ADRA2C
SCHEMBL31588004 0.76 EGFR (0.51) EGFRCA12CA2CA3CA6
SCHEMBL22032195 0.75 EGFR (0.39) ADRB2ADRA1ACYP4F2CYP4A11MTNR1A
SCHEMBL31588092 0.73 HTT (0.38) CYP4F2CYP4A11MTNR1AMTNR1BSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109415353-B Pegylated carfilzomib compounds 美国安进公司 2023-01-10 — — CN disclosed
EP-3464277-B1 PEGYLATED CARFILZOMIB COMPOUNDS AMGEN INC (US) 2022-12-28 — — EP disclosed
EP-3464277-B1 PEGYLATED CARFILZOMIB COMPOUNDS AMGEN INC (US) 2022-12-28 — — EP disclosed
US-10675353-B2 Pegylated carfilzomib compounds AMGEN INC. (US) 2020-06-09 — — US disclosed
US-20200069808-A1 PEGYLATED CARFILZOMIB COMPOUNDS AMGEN INC. 2020-03-05 — — US disclosed
US-20170340746-A1 PEGYLATED CARFILZOMIB COMPOUNDS AMGEN INC. 2017-11-30 — — US disclosed
US-20170340746-A1 PEGYLATED CARFILZOMIB COMPOUNDS AMGEN INC. 2017-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170340746-A1 PEGYLATED CARFILZOMIB COMPOUNDS MCL1, FCGRT, MAN2B1 ALOX15 1615/4885CHRM2 4784/4885CHRM1 4592/4885
US-10675353-B2 Pegylated carfilzomib compounds FCGRT, EPOR, MCL1 ALOX15 1615/4885CHRM2 4637/4885CHRM1 4289/4885
US-20200069808-A1 PEGYLATED CARFILZOMIB COMPOUNDS FCGRT, EPOR, MCL1 ALOX15 1615/4885CHRM2 4637/4885CHRM1 4289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback